Chris Howerton
Stock Analyst at Jefferies
(3.10)
# 1,236
Out of 4,413 analysts
56
Total ratings
43.33%
Success rate
12.11%
Average return
Main Sectors:
Top Industries:
32 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Buy | $50 → $79 | $39.32 | +100.92% | 2 | Sep 29, 2023 | |
| MIST Milestone Pharmaceuticals | Downgrades: Hold | $8 → $4 | $1.60 | +150.00% | 3 | Jun 20, 2023 | |
| VERU Veru Inc. | Upgrades: Hold | $1 | $1.49 | -32.89% | 3 | Jun 7, 2023 | |
| BTAI BioXcel Therapeutics | Downgrades: Hold | $20 → $22 | $2.54 | +766.14% | 2 | Mar 10, 2023 | |
| AVTX Avalo Therapeutics | Downgrades: Underperform | $720 | $16.04 | +4,388.78% | 2 | Feb 8, 2023 | |
| CGEN Compugen | Downgrades: Underperform | $0.5 | $1.99 | -74.87% | 2 | Feb 8, 2023 | |
| URGN UroGen Pharma | Downgrades: Hold | $35 → $10 | $14.40 | -30.56% | 1 | Feb 8, 2023 | |
| MEIP MEI Pharma | Downgrades: Underperform | $8 → $2 | $3.06 | -34.64% | 3 | Feb 8, 2023 | |
| LABP Landos Biopharma | Downgrades: Underperform | $2 → $1 | $22.29 | -95.51% | 3 | Jan 6, 2023 | |
| AVDL Avadel Pharmaceuticals | Upgrades: Buy | $6.5 → $11 | $18.31 | -39.92% | 3 | Nov 30, 2022 | |
| APLS Apellis Pharmaceuticals | Downgrades: Hold | $70 → $40 | $46.05 | -13.14% | 2 | Nov 10, 2022 | |
| HRMY Harmony Biosciences Holdings | Upgrades: Buy | $57 → $61 | $30.27 | +101.52% | 3 | Oct 14, 2022 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $92 → $90 | $74.89 | +20.18% | 3 | Sep 30, 2022 | |
| FNCH Finch Therapeutics Group | Maintains: Buy | $870 → $510 | $2.31 | +21,987.48% | 2 | Apr 4, 2022 | |
| ARDX Ardelyx | Upgrades: Buy | $1 → $5 | $6.61 | -24.36% | 3 | Mar 2, 2022 | |
| VNDA Vanda Pharmaceuticals | Downgrades: Hold | $24 → $12 | $4.77 | +151.57% | 1 | Feb 25, 2022 | |
| IGMS IGM Biosciences | Maintains: Buy | n/a | $9.48 | - | 1 | Dec 13, 2021 | |
| IOBT IO Biotech | Initiates: Buy | n/a | $1.55 | - | 1 | Nov 30, 2021 | |
| CLDX Celldex Therapeutics | Initiates: Buy | n/a | $39.35 | - | 1 | Sep 17, 2021 | |
| OMGA Omega Therapeutics | Initiates: Buy | n/a | $2.48 | - | 1 | Aug 24, 2021 | |
| CADL Candel Therapeutics | Initiates: Buy | n/a | $7.98 | - | 1 | Aug 23, 2021 | |
| TCRX TScan Therapeutics | Initiates: Buy | n/a | $8.62 | - | 1 | Aug 10, 2021 | |
| HOWL Werewolf Therapeutics | Initiates: Buy | n/a | $6.02 | - | 1 | May 25, 2021 | |
| LVTX LAVA Therapeutics | Initiates: Buy | n/a | $2.97 | - | 1 | Apr 19, 2021 | |
| EVLO Evelo Biosciences | Upgrades: Buy | n/a | $0.05 | - | 2 | Apr 12, 2021 | |
| ACAD ACADIA Pharmaceuticals | Downgrades: Hold | n/a | $17.05 | - | 2 | Apr 6, 2021 | |
| MCRB Seres Therapeutics | Upgrades: Buy | n/a | $1.08 | - | 1 | Aug 11, 2020 | |
| BLPH Bellerophon Therapeutics | Initiates: Buy | n/a | $0.05 | - | 1 | Aug 11, 2020 | |
| TXMD TherapeuticsMD | Downgrades: Underperform | n/a | $1.89 | - | 1 | Aug 7, 2020 | |
| CORT Corcept Therapeutics | Downgrades: Hold | n/a | $23.88 | - | 1 | Aug 5, 2020 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | n/a | $25.56 | - | 1 | Jul 15, 2020 | |
| LYRA Lyra Therapeutics | Initiates: Buy | n/a | $5.25 | - | 1 | May 26, 2020 |
Structure Therapeutics
Sep 29, 2023
Maintains: Buy
Price Target: $50 → $79
Current: $39.32
Upside: +100.92%
Milestone Pharmaceuticals
Jun 20, 2023
Downgrades: Hold
Price Target: $8 → $4
Current: $1.60
Upside: +150.00%
Veru Inc.
Jun 7, 2023
Upgrades: Hold
Price Target: $1
Current: $1.49
Upside: -32.89%
BioXcel Therapeutics
Mar 10, 2023
Downgrades: Hold
Price Target: $20 → $22
Current: $2.54
Upside: +766.14%
Avalo Therapeutics
Feb 8, 2023
Downgrades: Underperform
Price Target: $720
Current: $16.04
Upside: +4,388.78%
Compugen
Feb 8, 2023
Downgrades: Underperform
Price Target: $0.5
Current: $1.99
Upside: -74.87%
UroGen Pharma
Feb 8, 2023
Downgrades: Hold
Price Target: $35 → $10
Current: $14.40
Upside: -30.56%
MEI Pharma
Feb 8, 2023
Downgrades: Underperform
Price Target: $8 → $2
Current: $3.06
Upside: -34.64%
Landos Biopharma
Jan 6, 2023
Downgrades: Underperform
Price Target: $2 → $1
Current: $22.29
Upside: -95.51%
Avadel Pharmaceuticals
Nov 30, 2022
Upgrades: Buy
Price Target: $6.5 → $11
Current: $18.31
Upside: -39.92%
Apellis Pharmaceuticals
Nov 10, 2022
Downgrades: Hold
Price Target: $70 → $40
Current: $46.05
Upside: -13.14%
Harmony Biosciences Holdings
Oct 14, 2022
Upgrades: Buy
Price Target: $57 → $61
Current: $30.27
Upside: +101.52%
Axsome Therapeutics
Sep 30, 2022
Maintains: Buy
Price Target: $92 → $90
Current: $74.89
Upside: +20.18%
Finch Therapeutics Group
Apr 4, 2022
Maintains: Buy
Price Target: $870 → $510
Current: $2.31
Upside: +21,987.48%
Ardelyx
Mar 2, 2022
Upgrades: Buy
Price Target: $1 → $5
Current: $6.61
Upside: -24.36%
Vanda Pharmaceuticals
Feb 25, 2022
Downgrades: Hold
Price Target: $24 → $12
Current: $4.77
Upside: +151.57%
IGM Biosciences
Dec 13, 2021
Maintains: Buy
Price Target: n/a
Current: $9.48
Upside: -
IO Biotech
Nov 30, 2021
Initiates: Buy
Price Target: n/a
Current: $1.55
Upside: -
Celldex Therapeutics
Sep 17, 2021
Initiates: Buy
Price Target: n/a
Current: $39.35
Upside: -
Omega Therapeutics
Aug 24, 2021
Initiates: Buy
Price Target: n/a
Current: $2.48
Upside: -
Candel Therapeutics
Aug 23, 2021
Initiates: Buy
Price Target: n/a
Current: $7.98
Upside: -
TScan Therapeutics
Aug 10, 2021
Initiates: Buy
Price Target: n/a
Current: $8.62
Upside: -
Werewolf Therapeutics
May 25, 2021
Initiates: Buy
Price Target: n/a
Current: $6.02
Upside: -
LAVA Therapeutics
Apr 19, 2021
Initiates: Buy
Price Target: n/a
Current: $2.97
Upside: -
Evelo Biosciences
Apr 12, 2021
Upgrades: Buy
Price Target: n/a
Current: $0.05
Upside: -
ACADIA Pharmaceuticals
Apr 6, 2021
Downgrades: Hold
Price Target: n/a
Current: $17.05
Upside: -
Seres Therapeutics
Aug 11, 2020
Upgrades: Buy
Price Target: n/a
Current: $1.08
Upside: -
Bellerophon Therapeutics
Aug 11, 2020
Initiates: Buy
Price Target: n/a
Current: $0.05
Upside: -
TherapeuticsMD
Aug 7, 2020
Downgrades: Underperform
Price Target: n/a
Current: $1.89
Upside: -
Corcept Therapeutics
Aug 5, 2020
Downgrades: Hold
Price Target: n/a
Current: $23.88
Upside: -
Protagonist Therapeutics
Jul 15, 2020
Initiates: Buy
Price Target: n/a
Current: $25.56
Upside: -
Lyra Therapeutics
May 26, 2020
Initiates: Buy
Price Target: n/a
Current: $5.25
Upside: -